FREE SHIPPING with every SuperJeweler.com order! Shop Now
Published On: Tue, Nov 12th, 2019

Solid Biosciences gene therapy trial put on hold for second time, shares slump

Solid Biosciences Inc said on Tuesday the U.S. Food and Drug Administration had put on hold a trial testing its gene therapy for a muscle-wasting disorder, the second halt by the health regulator, sending its shares plunging 66%.


Reuters: Health News

FREE SHIPPING with every SuperJeweler.com order! Shop Now

About the Author

-

Leave a comment

XHTML: You can use these html tags: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <s> <strike> <strong>

Advertisements

Powered by WP Robot

Solid Biosciences gene therapy trial put on hold for second time, shares slump